These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12555173)

  • 21. Angiotensin-converting enzyme inhibitors or beta-blockers in heart failure: does it matter who goes first?
    Fang JC
    Circulation; 2005 Oct; 112(16):2380-2. PubMed ID: 16230494
    [No Abstract]   [Full Text] [Related]  

  • 22. Beta-blockers and reverse remodeling: what are the implications?
    Francis GS; Tang WH
    Am Heart J; 2003 Feb; 145(2):200-2. PubMed ID: 12595832
    [No Abstract]   [Full Text] [Related]  

  • 23. Managing patients with heart failure: the reality of clinical practice.
    Squire I
    Eur Heart J; 2005 Dec; 26(24):2611-3. PubMed ID: 16219652
    [No Abstract]   [Full Text] [Related]  

  • 24. Interaction of beta-blockers and angiotensin receptor blockers/ACE inhibitors in heart failure.
    Cohn JN
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):137-9. PubMed ID: 14608516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease.
    Vonder Muhll I; Liu P; Webb G
    Int J Cardiol; 2004 Dec; 97 Suppl 1():25-33. PubMed ID: 15590076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical trials in diastolic heart failure.
    Massie BM; Fabi MR
    Prog Cardiovasc Dis; 2005; 47(6):389-95. PubMed ID: 16115518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta blockers in systolic heart failure.
    Jackowski L; Azam R
    Aust Fam Physician; 2008 Mar; 37(3):137-9. PubMed ID: 18345362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.
    Guo X; Saini HK; Wang J; Gupta SK; Goyal RK; Dhalla NS
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):717-32. PubMed ID: 16076281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
    Rapp JA; Gheorghiade M
    Heart Fail Clin; 2005 Apr; 1(1):77-93. PubMed ID: 17386836
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chronic left heart failure. A focus on the pathogenetic basis of medical treatment].
    Novosel MK; Haghfelt TH
    Ugeskr Laeger; 2006 May; 168(19):1854-6. PubMed ID: 16756801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The HF epidemic: the need for new treatment strategies.
    Carson PE
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2 Suppl):S32-4. PubMed ID: 17199218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACE inhibitors and beta blockers in chronic congestive cardiac failure: therapeutic basis.
    Manoria PC; Manoria P
    J Indian Med Assoc; 2003 May; 101(5):311-2, 315. PubMed ID: 14575221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sudden cardiac death after heart failure; symptomatic versus disease treatment? An editorial comment.
    Buckberg GD;
    Heart Fail Rev; 2004 Oct; 9(4):347-51. PubMed ID: 15886980
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapy for diastolic heart failure.
    Little WC; Brucks S
    Prog Cardiovasc Dis; 2005; 47(6):380-8. PubMed ID: 16115517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional mitral regurgitation and chronic heart failure.
    Ennezat PV; Marechaux S; Asseman P; Lejemtel TH; Van Belle E; Bauters C; De Groote P
    Minerva Cardioangiol; 2006 Dec; 54(6):725-33. PubMed ID: 17167384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nebivolol in older adults with heart failure: reduced rates for seniors?
    Armstrong PW; Alexander KP
    J Am Coll Cardiol; 2009 Jun; 53(23):2159-61. PubMed ID: 19497442
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
    Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS
    Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of heart failure and preserved systolic function].
    Dahlström U; Boman K; Brodin LA; Hagerman I; Willenheimer R
    Lakartidningen; 2007 Aug 22-28; 104(34):2348-50. PubMed ID: 17907560
    [No Abstract]   [Full Text] [Related]  

  • 39. Can cardiac-resynchronization therapy reduce mortality in patients suffering from advanced chronic heart failure?
    Cleland JG; Ghosh J; Freemantle N
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):10-1. PubMed ID: 16265249
    [No Abstract]   [Full Text] [Related]  

  • 40. Chronic heart failure.
    Poole-Wilson PA
    Timely Top Med Cardiovasc Dis; 2007 Jan; 11():E2. PubMed ID: 18297148
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.